CSL Seqirus has signed a long-term agreement with The Pan American Health Organization (PAHO) to enhance regional influenza protection in the Americas. The company will supply its influenza vaccine portfolio, and with partner Sinergium Biotech, will localize vaccine filling and distribution, strengthening public health preparedness.
This strategic partnership with PAHO strengthens CSL Seqirus's position in the Latin American influenza vaccine market. By localizing filling and distribution, it enhances regional supply chain security and pandemic preparedness, potentially leading to increased market share and improved public health outcomes across multiple countries.
CSL Seqirus enters a long-term agreement with PAHO.
The partnership aims to advance regional influenza protection in the Americas.
CSL Seqirus will supply its influenza vaccine portfolio.
This agreement directly impacts the Region of the Americas, focusing on enhancing influenza vaccine availability and local manufacturing capabilities within Latin American countries through collaboration with PAHO and Sinergium Biotech.
CSL Seqirus will supply its influenza vaccine portfolio.
Vaccine filling and distribution will be localized with partner Sinergium Biotech.
Sign in to save notes on signals.
Sign In